Tagrisso (Osimertinib) Tarceva (Erlotinib) Erbitux (Cetuximab) Iressa (Gefitinib) Gilotrif (Afatinib) Vectibix (Panutumamab)

August 28, 2025

In Depth Overview of Tyrosine Kinase Inhibitor Treatment of EGFR + Lung Cancer

Charles H. Weaver, MD
August 21, 2025

Tagrisso – First Precision Medicine Approved for Treatment of Early Stage NSCLC

Charles H. Weaver, MD
November 1, 2023

CancerConnect – November is Lung Cancer Awareness Month

Charles H. Weaver, MD
September 7, 2023

Tagrisso® – Standard of Care for EGFR + Non Small Cell Lung Cancer

Charles H. Weaver, MD
February 2, 2021

Precision Cancer Medicines & Immunotherapy for Lung Cancer

Charles H. Weaver, MD
November 7, 2019

KRAS Gene Mutation Linked with Poor Response to Erbitux® in Colorectal Cancer

Charles H. Weaver, MD
January 1, 2012

Erbitux® Treatment for Metastatic Colorectal Cancer

Charles H. Weaver, MD